Pliant Therapeutics
PLRX
PLRX
81 hedge funds and large institutions have $893M invested in Pliant Therapeutics in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.44% less ownership
Funds ownership: 85.95% → 85.51% (-0.44%)
26% less capital invested
Capital invested by funds: $1.21B → $893M (-$314M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $189K
Holders
81
Holding in Top 10
4
Calls
–
Puts
$189K
Top Buyers
| 1 | +$4.92M | |
| 2 | +$4.41M | |
| 3 | +$3.5M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$2.09M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.49M |
Top Sellers
| 1 | -$7.99M | |
| 2 | -$3.76M | |
| 3 | -$3.41M | |
| 4 |
Bank of New York Mellon
New York
|
-$3.4M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$1.48M |